Filed: 5/2/2025ACC: 0001999371-25-005352
π What this filing means
WILDCAT CAPITAL MANAGEMENT, LLC filed this quarterly 13FβHR report disclosing 8 equity positions with a total reported market value of $187.39M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
8
Positions
$187.39M
Total AUM (reported)
52.72M
Total Shares
Allocation by class
COM$149.28M79.7%
SPONSORED ADS$37.98M20.3%
SHS NEW$124.8K0.1%
Portfolio Concentration
Top 3$172.39M92.0%
4β10$14.99M8.0%
Top 3 weight
92.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 52.72M
Sole
Full voting authority
52.72M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole8
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings8
Rows:
FRONTIER GROUP HLDGS INC
SOLEShares28.06M
TypeSH
Market value$121.79M
64.99%
Sole
28.06M
Shared
0.00
None
0.00
RLX TECHNOLOGY INC
SOLEShares18.05M
TypeSH
Market value$33.93M
18.11%
Sole
18.05M
Shared
0.00
None
0.00
ACUREN CORP
SOLEShares1.50M
TypeSH
Market value$16.68M
8.90%
Sole
1.50M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares495.61K
TypeSH
Market value$5.48M
2.93%
Sole
495.61K
Shared
0.00
None
0.00
ALLOGENE THERAPEUTICS INC
SOLEShares2.92M
TypeSH
Market value$4.26M
2.28%
Sole
2.92M
Shared
0.00
None
0.00
CENTESSA PHARMACEUTICALS PLC
SOLEShares281.86K
TypeSH
Market value$4.05M
2.16%
Sole
281.86K
Shared
0.00
None
0.00
KRONOS BIO INC
SOLEShares1.30M
TypeSH
Market value$1.07M
0.57%
Sole
1.30M
Shared
0.00
None
0.00
SILEXION THERAPEUTICS CORP
SOLEShares113.43K
TypeSH
Market value$124.8K
0.07%
Sole
113.43K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
FRONTIER GROUP HLDGS INCSOLE | COM | 28.06M | SH | $121.79M 64.99% | 28.06M | 0.00 | 0.00 |
RLX TECHNOLOGY INCSOLE | SPONSORED ADS | 18.05M | SH | $33.93M 18.11% | 18.05M | 0.00 | 0.00 |
ACUREN CORPSOLE | COM | 1.50M | SH | $16.68M 8.90% | 1.50M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 495.61K | SH | $5.48M 2.93% | 495.61K | 0.00 | 0.00 |
ALLOGENE THERAPEUTICS INCSOLE | COM | 2.92M | SH | $4.26M 2.28% | 2.92M | 0.00 | 0.00 |
CENTESSA PHARMACEUTICALS PLCSOLE | SPONSORED ADS | 281.86K | SH | $4.05M 2.16% | 281.86K | 0.00 | 0.00 |
KRONOS BIO INCSOLE | COM | 1.30M | SH | $1.07M 0.57% | 1.30M | 0.00 | 0.00 |
SILEXION THERAPEUTICS CORPSOLE | SHS NEW | 113.43K | SH | $124.8K 0.07% | 113.43K | 0.00 | 0.00 |